Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana

In 2020, Dihydroartemisinin-Piperaquine (DHAP) was adopted as a second-line antimalarial for treatment of uncomplicated malaria in Ghana following a review of the country’s antimalarial medicines policy. Available data obtained in 2007 had shown PCR-uncorrected therapeutic efficacy of 93.3% using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuaku, Benjamin, Boateng, Paul, Peprah, Nana Yaw, Asamoah, Alexander, Duah-Quashie, Nancy Odurowah, Matrevi, Sena Adzoa, Amoako, Eunice Obeng, Quashie, Neils, Owusu-Antwi, Felicia, Malm, Keziah Laurencia, Koram, Kwadwo Ansah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853013/
https://www.ncbi.nlm.nih.gov/pubmed/36683700
http://dx.doi.org/10.3389/fcimb.2022.1058660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853013/
https://www.ncbi.nlm.nih.gov/pubmed/36683700
http://dx.doi.org/10.3389/fcimb.2022.1058660

Ejemplares similares